| Endothelial dysfunction in hypertension: current concepts and clinical implications G Gallo, M Volpe, C Savoia Frontiers in medicine 8, 798958, 2022 | 138 | 2022 |
| “Classical organic acidurias”: diagnosis and pathogenesis GRD Villani, G Gallo, E Scolamiero, F Salvatore, M Ruoppolo Clinical and experimental medicine 17, 305-323, 2017 | 107 | 2017 |
| Targeted metabolomics in the expanded newborn screening for inborn errors of metabolism E Scolamiero, C Cozzolino, L Albano, A Ansalone, M Caterino, G Corbo, ... Molecular BioSystems 11 (6), 1525-1535, 2015 | 86 | 2015 |
| Maternal vitamin B12 deficiency detected in expanded newborn screening E Scolamiero, GRD Villani, L Ingenito, R Pecce, L Albano, M Caterino, ... Clinical biochemistry 47 (18), 312-317, 2014 | 79 | 2014 |
| Hypertension and COVID-19: current evidence and perspectives G Gallo, V Calvez, C Savoia High Blood Pressure & Cardiovascular Prevention 29 (2), 115-123, 2022 | 77 | 2022 |
| Is early and fast blood pressure control important in hypertension management? M Volpe, G Gallo, G Tocci International Journal of Cardiology 254, 328-332, 2018 | 74 | 2018 |
| Lipoprotein (a) is related to coronary atherosclerotic burden and a vulnerable plaque phenotype in angiographically obstructive coronary artery disease G Niccoli, D Cin, G Scalone, M Panebianco, S Abbolito, N Cosentino, ... Atherosclerosis 246, 214-220, 2016 | 43 | 2016 |
| Role of oxidative stress in the process of vascular remodeling following coronary revascularization G Gallo, G Pierelli, M Forte, R Coluccia, M Volpe, S Rubattu International journal of cardiology 268, 27-33, 2018 | 41 | 2018 |
| Gender and age normalization and ventilation efficiency during exercise in heart failure with reduced ejection fraction E Salvioni, U Corrà, M Piepoli, S Rovai, M Correale, S Paolillo, ... ESC heart failure 7 (1), 368-377, 2020 | 38 | 2020 |
| Highlights of ESC/ESH 2018 guidelines on the management of hypertension: what every doctor should know M Volpe, G Gallo, A Battistoni, G Tocci High Blood Pressure & Cardiovascular Prevention 26, 1-8, 2019 | 33 | 2019 |
| Insulin‐resistance in glycogen storage disease type Ia: linking carbohydrates and mitochondria? A Rossi, M Ruoppolo, P Formisano, G Villani, L Albano, G Gallo, D Crisci, ... Journal of inherited metabolic disease 41 (6), 985-995, 2018 | 30 | 2018 |
| Implications of guidelines for hypertension management in Europe M Volpe, G Gallo, A Battistoni, G Tocci Circulation Research 124 (7), 972-974, 2019 | 24 | 2019 |
| Executive summary of the 2018 joint consensus document on cardiovascular disease prevention in Italy M Volpe, A Battistoni, G Gallo, S Rubattu, G Tocci, ... High Blood Pressure & Cardiovascular Prevention 25 (3), 327-341, 2018 | 24 | 2018 |
| The reduction of NDUFC2 expression is associated with mitochondrial impairment in circulating mononuclear cells of patients with acute coronary syndrome S Raffa, XLD Chin, R Stanzione, M Forte, F Bianchi, M Cotugno, ... International journal of cardiology 286, 127-133, 2019 | 23 | 2019 |
| Angiotensin receptor blockers in the management of hypertension: a real-world perspective and current recommendations G Gallo, M Volpe, S Rubattu Vascular Health and Risk Management, 507-515, 2022 | 22 | 2022 |
| Sacubitril/valsartan for the management of heart failure: a perspective viewpoint on current evidence M Volpe, J Bauersachs, A Bayes-Genis, J Butler, A Cohen-Solal, G Gallo, ... International Journal of Cardiology 327, 138-145, 2021 | 19 | 2021 |
| New approach to blood pressure control: triple combination pill M Volpe, G Gallo, G Tocci Trends in Cardiovascular Medicine 30 (2), 72-77, 2020 | 19 | 2020 |
| Blockade of the neurohormonal systems in heart failure with preserved ejection fraction: a contemporary meta-analysis G Gallo, G Tocci, F Fogacci, A Battistoni, S Rubattu, M Volpe International Journal of Cardiology 316, 172-179, 2020 | 18 | 2020 |
| Obesity and cardiovascular disease: An executive document on pathophysiological and clinical links promoted by the Italian Society of Cardiovascular Prevention (SIPREC) M Volpe, G Gallo Frontiers in Cardiovascular Medicine 10, 1136340, 2023 | 17 | 2023 |
| Sacubitril/valsartan as a therapeutic tool across the range of heart failure phenotypes and ejection fraction spectrum G Gallo, M Volpe, A Battistoni, D Russo, G Tocci, MB Musumeci Frontiers in Physiology 12, 652163, 2021 | 17 | 2021 |
